Tiverton Asset Management’s Edwards Lifesciences EW Stock Holding History

Tiverton Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$683K	Sell	9,315 -2,796	-23%	-$196K	0.02%	343
2019 Q2	$746K	Buy	12,111 +30	+0.2%	+$1.81K	0.03%	308
2019 Q1	$771K	Buy	12,081 +4,587	+61%	+$262K	0.03%	272
2018 Q4	$383K	Buy	7,494 +657	+10%	+$33.2K	0.02%	251
2018 Q3	$397K	Hold	6,837	–	–	0.02%	268
2018 Q2	$332K	Buy	6,837 +177	+3%	+$8.26K	0.02%	277
2018 Q1	$310K	Sell	6,660 -15	-0.2%	-$651	0.02%	264
2017 Q4	$251K	Buy	+6,675	New	+$245K	0.02%	329

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Tiverton Asset Management's EW Position: Q3 2019 in Review

Tiverton Asset Management reduced its Edwards Lifesciences (EW) stake by 23% in Q3 2019, selling an estimated $196K and leaving 9,315 shares worth $683K. The position accounts for 0.02% of the portfolio, ranked #343.

Tiverton Asset Management first reported a position in EW in Q4 2017 and has held it in 8 quarters since. The position peaked at $771K in Q1 2019. 964 funds tracked by Wall St. Rank hold EW as of Q3 2019.

Tiverton Asset Management held 9,315 shares of Edwards Lifesciences worth $683K as of Q3 2019.
Tiverton Asset Management sold 2,796 Edwards Lifesciences shares in Q3 2019, an estimated $196K.
Edwards Lifesciences made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #343 holding.
Tiverton Asset Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 8 quarters since.
Tiverton Asset Management's Edwards Lifesciences position peaked at $771K in Q1 2019.
964 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.